UMP Healthcare Holdings Limited (722) has announced that its board of directors will convene on Wednesday, 25 February 2026. The primary agenda includes reviewing and approving the unaudited condensed consolidated interim results for the six-month period ended 31 December 2025, along with considering any payment of an interim dividend and discussing other business matters.
According to the announcement, the outcome of the meeting and any relevant decisions are expected to be published following the board’s deliberations. As stated, the meeting date and purposes have been confirmed in the most recent company update issued on 10 February 2026.